Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

Mohamed A AlMaatouqEndocrine Unit, Department of Medicine, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi ArabiaAbstract: More than 50 million Muslims throughout the world with type 2 diabetes mellitus (T2DM) fast for one lunar month (Ramadan) each year....

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	AlMaatouq MA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/6a27290c89504f4a94d6d15496c21fa4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6a27290c89504f4a94d6d15496c21fa4
record_format	dspace
spelling	oai:doaj.org-article:6a27290c89504f4a94d6d15496c21fa42021-12-02T02:28:46ZPharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan1178-7007https://doaj.org/article/6a27290c89504f4a94d6d15496c21fa42012-05-01T00:00:00Zhttp://www.dovepress.com/pharmacological-approaches-to-the-management-of-type-2-diabetes-in-fas-a9794https://doaj.org/toc/1178-7007Mohamed A AlMaatouqEndocrine Unit, Department of Medicine, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi ArabiaAbstract: More than 50 million Muslims throughout the world with type 2 diabetes mellitus (T2DM) fast for one lunar month (Ramadan) each year. Health care providers within and outside the Muslim world need to be aware of the nature of these partial days of fasting and their risks (and potential benefits) to people with T2DM, and need to provide Ramadan-adjusted diabetes care. Hypoglycemia during the fasting days represents the greatest health risk for these patients; hence, diabetes-related pharmacotherapy needs to be tailored and adjusted with this risk in mind. With limited trial data available, this review proposes practical modifications to the usual pre-Ramadan antidiabetic regimens that are based on pathophysiological principles, clinical trial evidence (where available), expert opinion, and extended practical experience. Individualization of care is paramount in this regard to take into consideration the patient and societal, cultural, and economic variables.Keywords: type 2 diabetes mellitus, Ramadan, fasting, hypoglycemia, oral antidiabetic agents, insulinAlMaatouq MADove Medical PressarticleSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol 2012, Iss default, Pp 109-119 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Specialties of internal medicine RC581-951
spellingShingle	Specialties of internal medicine RC581-951 AlMaatouq MA Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
description	Mohamed A AlMaatouqEndocrine Unit, Department of Medicine, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi ArabiaAbstract: More than 50 million Muslims throughout the world with type 2 diabetes mellitus (T2DM) fast for one lunar month (Ramadan) each year. Health care providers within and outside the Muslim world need to be aware of the nature of these partial days of fasting and their risks (and potential benefits) to people with T2DM, and need to provide Ramadan-adjusted diabetes care. Hypoglycemia during the fasting days represents the greatest health risk for these patients; hence, diabetes-related pharmacotherapy needs to be tailored and adjusted with this risk in mind. With limited trial data available, this review proposes practical modifications to the usual pre-Ramadan antidiabetic regimens that are based on pathophysiological principles, clinical trial evidence (where available), expert opinion, and extended practical experience. Individualization of care is paramount in this regard to take into consideration the patient and societal, cultural, and economic variables.Keywords: type 2 diabetes mellitus, Ramadan, fasting, hypoglycemia, oral antidiabetic agents, insulin
format	article
author	AlMaatouq MA
author_facet	AlMaatouq MA
author_sort	AlMaatouq MA
title	Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
title_short	Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
title_full	Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
title_fullStr	Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
title_full_unstemmed	Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
title_sort	pharmacological approaches to the management of type 2 diabetes in fasting adults during ramadan
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/6a27290c89504f4a94d6d15496c21fa4
work_keys_str_mv	AT almaatouqma pharmacologicalapproachestothemanagementoftype2diabetesinfastingadultsduringramadan
_version_	1718402474174316544

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

Ejemplares similares